Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres

Clin Microbiol Infect. 2005 Jun;11(6):505-7. doi: 10.1111/j.1469-0691.2005.01114.x.

Abstract

The proportion of ciprofloxacin-resistant Gram-negative bacteria isolated from the blood of children with cancer (not receiving prophylaxis) was 10% in a paediatric hospital (Genoa) where the use of quinolones was highly restricted, compared with 41% in a department of haematology (Rome) where leukaemic adults, who received fluoroquinolone prophylaxis, were also treated (p < 0.0001). Moreover, simultaneous resistance to ciprofloxacin and ceftazidime, amikacin or imipenem-cilastatin was 11% in Genoa compared with 37% in Rome (p < 0.001). Ciprofloxacin resistance was more frequent in children who shared an environment with adults who were receiving ciprofloxacin prophylaxis.

Publication types

  • Comparative Study

MeSH terms

  • Amikacin / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / microbiology*
  • Bacteremia / prevention & control
  • Ceftazidime / pharmacology
  • Child
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Multiple, Bacterial
  • Fluoroquinolones / pharmacology*
  • Fluoroquinolones / therapeutic use
  • Gram-Negative Bacteria / drug effects*
  • Gram-Negative Bacteria / isolation & purification
  • Gram-Negative Bacterial Infections / microbiology*
  • Gram-Negative Bacterial Infections / prevention & control
  • Hospitals, Pediatric
  • Humans
  • Imipenem / pharmacology
  • Italy
  • Neoplasms / blood
  • Neoplasms / complications*
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Ciprofloxacin
  • Imipenem
  • Amikacin
  • Ceftazidime